Operating Lease, Right-of-Use Asset of Amneal Pharmaceuticals, Inc. from 01 Jan 2019 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Amneal Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2019 to 31 Dec 2024.
  • Amneal Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2024 was $42,352,000, a 2.2% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Amneal Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $42,352,000 -$931,000 -2.2% 31 Dec 2024 10-K 28 Feb 2025 2024 FY
Q4 2023 $43,283,000 -$12,838,000 -23% 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q4 2022 $56,121,000 -$4,249,000 -7% 31 Dec 2022 10-K 14 Mar 2024 2023 FY
Q4 2021 $60,370,000 +$1,631,000 +2.8% 31 Dec 2021 10-K 03 Mar 2023 2022 FY
Q4 2020 $58,739,000 -$11,133,000 -16% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q4 2019 $69,872,000 -$15,128,000 -18% 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q3 2019 $71,385,000 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 $76,931,000 30 Jun 2019 10-Q 05 Aug 2019 2019 Q2
Q1 2019 $80,803,000 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 $85,000,000 01 Jan 2019 10-K 02 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.